The Nigerian government aims to get 70 million Johnson and Johnson single-shot COVID-19 vaccines after the African Union recently announced a deal with the drugmaker for 400 million vaccine doses.
The FG also disclosed that some AstraZeneca proportion may be replaced by the new single-shot vaccine due to constraints to its vaccine value chain.
This was disclosed by NPHCDA boss, Dr. Faisal Shuaib in an interview with Reuters. He disclosed that Nigeria expects to receive an initial 30 million J&J vaccines by July.
“We’re hoping that we’ll be able to get up to 70 million doses of the Johnson & Johnson this year. This is yet to be finalised but these are some of the advanced conversations that are going on between Nigeria and the African Union.
Some of the allocations that we were supposed to get for the AstraZeneca will be replaced by the Johnson and Johnson,” Faisal said.
What you should know
- The African Union will receive 220 million doses of the Johnson and Johnson (J&J) single-shot vaccine through the African Vaccine Acquisition Trust (AVAT).
- The was disclosed by the African Export-Import Bank (Afreximbank) in a statement on Monday. They added that a potential 180 million vaccines could also be purchased after the vaccine purchase agreement was signed.